Plasmid DNA including the simian virus 40 (SV40) origin of replication undergoes uncontrolled, runawax ,'eplication in cos-I cells owing to the intracellular production of SV40 large T antigen. Covalent linkage of such plasmids with human papillomavirus type !6 (HPV-1 6) DNA was found to prevent runaway replication. Replication control was found to be dependent on the presence ofHPV-16 DNA sequences including the El open reading frame and part of the non-coding region.
The human papil!omavirus (HPV) group includes the causative agents of warts,, which are usually benign epithelial turnouts. Some viral types are also associated with pre-malignant disease and malignant disease . Evidence has accumulated implicating HPVs as one link in the chain of events leading to cervical cancer (reviewed in Broker & Botchan, 1986) . In non-malignant and pre-malignant cells, viral DNA is usually found in episomal form, whereas malignant cells contain DNA integrated within the host genome (Boshart et aL, 1984; Schwarz et al., 1985; Dfirst et a[., 1983) . It has been shown that integration is probably an early event in malignant conversion and may be a step in progression rather than a response to it (SchneiderMaunoury eta/., 1987) . Furthermore, bovine papillomavirus (BPV) type 1 replication and transformation functions are known to be inter-related (reviewed in Lambert et al., 1988) . These facts indicate that a study of the replication of HPV-16 in vitro may shed some light on the part played by HPV-I 6 in oncogenesis, It has been shown that HPV-16 and, less efficiently, HPV-6 DNA can transform rodent cells to malignancy in vitro. Both HPV-6 and HPV-16 DNA were found to be integrated within the host genome (Tsunokawa et al., 1986; Yasumoto et al., 1986; Matlashewski et al., 1987; Chesters & McCance, 1989 culture has been developed that is capable of supporting stable replication of HPV DNA. In an attempt to get around this problem we have investigated negative replication factors using a cell system developed for BPV-1. BPV-1 DNA replicates in rodent cells as a stable episome (Law eta/., 1981) and, in this form, transforms the cells to malignancy (Dvoretzky et al., 1980) . Analysis has shown that the 5' end of the open reading frame (ORF) of E1 encodes a negative factor that modulates DNA replication to control copy number, allowing the establishment of the viral genome as a stable nuclear episome (Berg et aL, 1986; Lusky & Botchan, 1985 , 1986 . The BPV-1 modulator was shown to function in cos-7 cells in which BPV DNA was allowed to replicate as part of a recombinant plasmid containing the simian virus 40 (SV40) origin of replication. Cos-7 cells are nonpermissive for BPV DNA replication, but will allow replication to proceed in an uncontrolled manner from an SV40 origin owing to the constitutive production of SV40 large T antigen by origin-defective SV40 DNA integrated with the cell genome. Covalently linking a plasmid containing an SV40 origin with BPV-1 DNA, and transfecting the hybrid into cos-7 cells, resulted in constraint of the usual uncontrolled, runaway replication from the SV40 origin, allowing the establishment of the DNA as a stable episome. This phenomenon was shown to be dependent on the expression of the 5' third of the El ORF, and the presence of BPV non-coding sequences, shown by Waldeck et al. (1984) to include an origin of replication (Roberts & Weintraub, 1986 (Seedorf et al., 1985) and is derived from more recent data (Matsukura et al., 1986; Baker et al., 1987; Bubb et al., 1988 Brackets denote the loss of the restriction site during construction.
religating, pRSV/HPV-16AP was made by digesting HPV-16 DNA cloned at the BamHI site of pRSVneo DNA (pRSV/HPV-16) with PvulI, which has two recognition sites in HPV-16 DNA within the E7 ORF at nucleotides 551 and 685 and three sites within the neo gene of pRSVneo (Gorman, 1985) . After religation, DNA containing the SV40 origin was cloned at the HindlII site. The SV40 origin DNA was derived from pSV2neo by digestion with HindlII and AccI, treatment with T4 polymerase to produce blunt ends and ligating with HindlII linkers (Bio Labs). The vector pRSVneo differs from pSV2neo (Southern & Berg, 1982) only in the substitution of the Rous sarcoma virus long terminal repeat for the SV40 origin between the HindlII and AccI sites of pSV2neo, pI6ES was a gift from Dr L. Laimins of the University of Chicago, I11., U.S.A. It consists of HPV-16 DNA sequences, between the EcoRI site at nucleotide 7454 and the StuI site at nucleotide 4466, cloned into the DNA vector pUC18 between the EcoRI and SmaI sites within the polylinker region of the vector. This construction was modified to produce pl6ES/SV40
by cloning the SV40 origin at the HindIII site within the pUC18 polylinker. These are shown in Fig. 1 . The HPV-16 DNA used was isolated in our laboratory from a grade III cervical intraepithelial neoplasia (CIN III) biopsy. Similar results (Fig. 2a) were obtained using prototype HPV-16 DNA (Dfirst et al., 1983; Seedorf et al., 1985) . DNA was transfected into cos-1 cells using the calcium phosphate coprecipitation method of Graham & van der Eb (1973) , with the addition of a glycerol shock 3 to 4 h after the DNA precipitate was applied. Cos-I cells are similar to cos-7 cells in the constitutive production of SV40 large T antigen (Gluzman, 1981) . Multiple plates were transfected with each DNA precipitate and, at intervals, cells were harvested and DNA was extracted by the procedure of Hirt (1967) . This DNA was digested with restriction endonuclease DpnI to degrade any nonreplicated (methylated) input DNA. The DNA was then either subjected to agarose gel electrophoresis for the preparation of a Southern blot onto nitrocellulose for hybridization, or used to transform Escherichia coli DH5 cells using a Bio-Rad Gene Pulser electroporation apparatus. Southern blots were hybridized with pAT153 DNA radiolabelled with 32p by the random primed oligolabelling method (Feinberg & Vogelstein, 1983) . Transformed bacteria were plated onto selective medium containing ampicillin and colonies were counted. As a control, to distinguish between colonies arising from the recovery of any input DNA remaining in the Hirt extract after DpnI treatment and those arising from bacterial transformation with replicated DNA, cos-1 cells to be used for bacterial transformation were cotransfected with pAT153 DNA and bacterial transformants were selected separately on ampicillin and on tetracycline. None of the DNA constructions used contain the gene for tetracycline resistance and so tetracycline selection will allow the growth only of bacteria transformed with pAT153 DNA. Since pAT153 DNA cannot replicate in cos-1 cells, this procedure gives a measure of the success of the DpnI treatment in eliminating residual input DNA from the Hirt extracts (Vassilev & Johnson, 1988) . As a result of this treatment, negligible input DNA was detected in the extracts. Initial experiments involved transfecting cos-1 cells with pSV2/HPV-16 DNA. Typical results are shown in Fig. 2(c) . Lanes 6 to 9 show pSV2/HPV-16 DNA taken at 24 h intervals, starting 24 h after the application of transfecting DNA (lane 6). It can be seen that there is an increase in the amount of DNA detected between 24 (lane 6) and 48 h ( of the pSV2neo DNA killing the host cells. Further evidence for this is given by the difficulty of subcloning transfected cells after G418 selection (also reported by Roberts & Weintraub, 1986) , and the fact that those cells which can be subcultured (albeit for only a few generations) contain pSV2neo DNA in a largely integrated state (Fig. 2a, lane 14) . The ladder of bands, seen clearly in Fig. 2 (c shows the levels of pSV2neo DNA rising rapidly up to 72 h and more slowly between 72 and 96 h. Again, the levels of pSV2/HPV-16 DNA are comparatively low. The initial small rise and subsequent decline of pSV2/HPV-16 DNA probably represents the establishment of a steady state, reflecting the time lag between initiation of replication and expression of sufficient modulator to exert control. The decline is unlikely to be caused by cell death in view of the much higher, and rising, levels of pSV2neo DNA at this time point. We next examined three deletion mutants of HPV-16 ( Fig. 1 ) to try to localize those sequences involved in regulation. The results are shown in Table 1 and Fig. 2 . Fig. 2(b,c) shows the results of a single transfection experiment.
The autoradiograph in Fig. 2(b) shows the yields of DNA recovered at different times from cos-1 cells transfected with pSV2/HPV-16AK, which lacks all the early region except for ORFs E6 and E7. The DNA pattern of replication is similar to that for pSV2neo DNA (Fig. 2c, lanes 1 to 4) with an initial increase from 24 (lane 1) to 48 (lane 2) and 72 h (lane 3), followed by a decrease between 72 and 96 h (lane 4). Lane 5 shows a marker consisting of an aliquot of DNA used for transfection. Table 1 shows the numbers of bacterial transformants obtained in a separate experiment. The two sets of results are broadly in agreement. Both pSV2neo and pSV2/HPV-16AK DNA showed an initial rise in replication over 72 h. The control plasmid pSV2neo then underwent a reduction in rate of replication, whereas pSV2/HPV-16AK DNA continued to These results indicate that pSV2/HPV-16AK and pRSV/HPV-16AP, like pSV2neo DNA, replicate in an uncontrolled manner and pl6ES/SV40, like pSV2/HPV-16, shows controlled replication, pRSV/HPV-16AP DNA lacks ORFs E6 and E7 and the entire non-coding region, but retains all the other ORFs including El, thought to be involved in replication, whereas pSV2/ HPV-16AK DNA retains ORFs E6 and E7 and the noncoding region, but lacks all other early ORFs.
This indicates that the non-coding region is necessary, but not sufficient, for replication control. Possibly it is the site of an origin of replication, p 16ES/SV40 retains the entire HPV-16 DNA early region intact, but lacks part of the non-coding region upstream of the EcoRI site at nucleotide 7454 (Fig. 1) . Since this construction retains control of replication, the non-coding sequences immediately 5' to the E60RF, downstream of the EcoRI site at nucleotide 7454, must house the relevant functional element(s). These results are similar to those obtained with BPV-1 DNA, indicating for the first time that ORF E1 of HPV-16 DNA may have similar functions to that of BPV-1 and that the origin of replication may be in the region lying between the EcoRI site at nucleotide 7454 and the start ofORF E6. Since the t DNA extracted at 48 h post-transfection. :~ HPV-16 DNA isolated from a CIN III biopsy in this laboratory and cloned into pAT153 at the BamHl site.
§ SV40 origin of replication cloned into pAT153 at the HindlII site. II TMTC, Too many to count.
prototype HPV-16 DNA construction showed the same behaviour as our isolate (Fig. 2a) , this also demonstrates that the frameshift in ORF E1 dividing it into two reading frames (Seedorf et al., 1985) has no effect on the modulation activity of E1 as measured in this system. It has been reported (Lehn, 1986 ) that HPV-16 DNA replication as indicated by the large number of transcells. Attempts to repeat this using HPV-16 DNA cloned into pAT153 at the BamHI site failed. Although control DNA, consisting of the SV40 origin cloned into the HindlII site of pAT153, exhibited high levels of replication as indicated by the large number of transformed bacteria, pAT153/HPV-16 DNA was present at a level indistinguishable from that expected for residual input DNA (Table 2) .
It is possible that the rate of DNA replication may be influenced by size, with larger DNA constructions replicating more slowly or reaching a steady state at a lower level. This is unlikely in view of the fact that the sizes of pSV2/HPV-16AK and pRSV/HPV-16AP DNA (approx. 9 kb) and ofpl6ES/SV40 DNA (approx. 8-2 kb) are similar, yet the first two replicate out of control whereas the last replicates in a controlled manner. Other experiments carried out on HPV by ourselves (results not shown) and on BPV by others (Roberts & Weintraub, 1986 ) confirm that size difference has little effect in this system.
Cotransfection experiments were performed using a control plasmid (pSN) sufficiently small to be clearly distinguishable from pSV2/HPV-16-recombinant DNA by gel electrophoresis and containing an SV40 origin, but no papillomavirus sequences. These experiments showed that runaway replication of the control plasmid occurred even in the same cell population in which the cotransfecting pSV2/HPV-16-recombinant DNA showed controlled replication (Fig. 2a) . This showed that the low amounts of pSV2/HPV-16 DNA detected reflected low levels of replication and not low transfection efficiency or low recovery of Hirt DNA. The results also indicate that sufficient replication factors are present in the cells used and that replication control is being exerted, mediated by those HPV-16 DNA sequences found to be necessary for the phenomenon to be observed.
Our assay cell system is somewhat remote from the natural host cell of HPV-16, terminally differentiating keratinocytes, but until recently it has not been possible to culture such cells in vitro. Now that such a system has been developed (Bell et al., 1983) and adapted for use with HPV (McCance et al., 1988) experiments are underway to use this system to determine the significance of the modulator factor inter alia in the natural history of HPV. These results indicate regions of the HPV-16 genome of interest for further study.
